O. Huillard
发表
F. Goldwasser,
R. Coriat,
L. Cynober,
2017,
Clinical nutrition.
B. Rousseau,
M. Bouattour,
O. Huillard,
2015,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
F. Goldwasser,
C. Tlemsani,
B. Blanchet,
2017,
Investigational New Drugs.
F. Goldwasser,
C. Tlemsani,
A. Jouinot,
2017,
Cancer Chemotherapy and Pharmacology.
M. Loriot,
F. Goldwasser,
R. Coriat,
2015,
Investigational New Drugs.
F. Goldwasser,
L. Golmard,
N. Sharifi,
2018,
Pharmacological research.
F. Goldwasser,
D. Dusser,
P. Boudou-Rouquette,
2014
.
E. Pasmant,
K. Leroy,
F. Goldwasser,
2022,
Thyroid : official journal of the American Thyroid Association.
F. Goldwasser,
B. Blanchet,
G. Noé,
2015,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
M. Schlumberger,
F. Goldwasser,
C. Tlemsani,
2019,
Thyroid : official journal of the American Thyroid Association.
F. Goldwasser,
R. Coriat,
L. Golmard,
2018,
Fundamental & clinical pharmacology.
M. Peyromaure,
F. Goldwasser,
M. Zerbib,
2020,
Clinical genitourinary cancer.
S. Culine,
Y. Loriot,
K. Fizazi,
2020,
European journal of cancer.
F. Goldwasser,
J. Clerc,
L. Groussin,
2015,
Clinical Cancer Research.
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
F. Goldwasser,
C. Tlemsani,
I. Colombet,
2017,
BMC Palliative Care.
M. Peyromaure,
F. Goldwasser,
E. Xylinas,
2016,
Clinical Cancer Research.
B. Escudier,
Y. Loriot,
M. Palma,
2013
.
F. Goldwasser,
R. Coriat,
B. Blanchet,
2014,
Expert opinion on drug safety.
J. Calvet,
F. Goldwasser,
T. Maisonobe,
2016,
Journal of Neuro-Oncology.
F. Goldwasser,
O. Huillard,
L. Hirsch,
2022,
Therapeutics and clinical risk management.
M. Revel,
M. Peyromaure,
F. Goldwasser,
2022,
Cancers.
F. Goldwasser,
C. Tlemsani,
A. Jouinot,
2016,
Expert opinion on drug metabolism & toxicology.
F. Goldwasser,
C. Dubertret,
J. Mallet,
2018,
European journal of cancer.
F. Goldwasser,
R. Cohen,
E. Curis,
2019,
British journal of clinical pharmacology.
F. Goldwasser,
B. Blanchet,
J. Alexandre,
2017,
Clinical genitourinary cancer.
F. Goldwasser,
B. Blanchet,
J. Durand,
2015,
The Lancet.
F. Goldwasser,
B. Blanchet,
A. Thomas-Schoemann,
2014,
The oncologist.
S. Culine,
Y. Allory,
W. Hilgers,
2021,
Clinical genitourinary cancer.
F. Goldwasser,
A. Hulin,
B. Rousseau,
2016,
Breast Cancer Research and Treatment.
S. Culine,
Y. Allory,
S. Oudard,
2019,
Clinical genitourinary cancer.
M. Peyromaure,
F. Goldwasser,
C. Goulvestre,
2022,
Clinical genitourinary cancer.
F. Goldwasser,
C. Tlemsani,
M. Wislez,
2021,
Clinical medicine.
F. Goldwasser,
C. Dubertret,
J. Mallet,
2019,
Journal of the National Cancer Institute.
C. Dubertret,
J. Mallet,
O. Huillard,
2017,
JAMA oncology.
F. Goldwasser,
Jeanne Chen,
O. Huillard,
2022
.
P. Leprince,
M. Schlumberger,
A. Dohan,
2021,
European Thyroid Journal.
F. Goldwasser,
S. Oudard,
B. Blanchet,
2017,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
J. Golmard,
F. Goldwasser,
G. Orvoen,
2017,
Cancer Chemotherapy and Pharmacology.
M. Sibony,
E. Xylinas,
M. Zerbib,
2018,
Front. Surg..
M. Schlumberger,
C. Chougnet,
Thierry Nguyen,
2017,
Thyroid : official journal of the American Thyroid Association.
Ocular adverse events of molecularly targeted agents approved in solid tumours: a systematic review.
L. Desjardins,
S. Bakalian,
M. Sablin,
2014,
European journal of cancer.
F. Goldwasser,
N. Dupin,
C. Csajka,
2020,
Cancers.
C. Tournigand,
K. Bensalah,
J. Bernhard,
2022,
The Lancet. Oncology.
F. Goldwasser,
C. Tlemsani,
B. Blanchet,
2015,
Expert opinion on investigational drugs.
O. Mir,
F. Goldwasser,
C. Tlemsani,
2011,
Targeted Oncology.
F. Goldwasser,
C. Tlemsani,
R. Coriat,
2015,
Expert opinion on drug metabolism & toxicology.
A. Ravaud,
B. Escudier,
G. Gravis,
2020,
European journal of cancer.
F. Goldwasser,
J. Guibourdenche,
M. Zerbib,
2017,
European journal of cancer.
O. Mir,
M. Peyromaure,
F. Goldwasser,
2013,
British Journal of Cancer.
K. Leroy,
F. Goldwasser,
N. Dupin,
2017,
Investigational new drugs.
K. Leroy,
F. Goldwasser,
N. Dupin,
2017,
Investigational New Drugs.
J. Clerc,
L. Groussin,
O. Huillard,
2023,
Cancers.
F. Goldwasser,
J. Clerc,
L. Groussin,
2017,
Journal of the Endocrine Society.
J. Clerc,
S. Garinet,
L. Groussin,
2021,
Thyroid : official journal of the American Thyroid Association.
F. Goldwasser,
L. Cynober,
A. Jouinot,
2017,
The American journal of clinical nutrition.
F. Goldwasser,
A. Bellesoeur,
J. Alexandre,
2017,
Drug design, development and therapy.
M. Peyromaure,
F. Goldwasser,
M. Zerbib,
2018,
Annals of oncology : official journal of the European Society for Medical Oncology.
F. Goldwasser,
L. Golmard,
B. Blanchet,
2016,
Oncotarget.
F. Goldwasser,
L. Morin,
R. Aubry,
2018,
Cancer.
F. Goldwasser,
M. Fontenay,
P. Boudou-Rouquette,
2015,
Cancer Chemotherapy and Pharmacology.
P. Chanson,
G. Assié,
B. Goichot,
2022,
European journal of endocrinology.
F. Goldwasser,
C. Tlemsani,
I. Colombet,
2015,
The oncologist.
J. Clerc,
L. Groussin,
O. Huillard,
2020,
The New England journal of medicine.
C. Dubertret,
J. Mallet,
B. Pignon,
2021,
L'Encéphale.
T. Lebret,
N. Delongchamps,
P. Paterlini-Bréchot,
2023,
Cancers.
F. Goldwasser,
N. Pallet,
P. Sogni,
2023,
British journal of clinical pharmacology.
F. Goldwasser,
O. Huillard,
2020,
European Journal of Cancer.
F. Goldwasser,
B. Blanchet,
A. Thomas-Schoemann,
2016,
Annals of oncology : official journal of the European Society for Medical Oncology.
F. Goldwasser,
J. Alexandre,
O. Huillard,
2016,
The New England journal of medicine.
M. Sibony,
J. Bertherat,
G. Assié,
2023,
Clinical nuclear medicine.
S. Oudard,
N. Houédé,
D. Pfister,
2022,
Annals of Oncology.
F. Goldwasser,
R. Coriat,
B. Blanchet,
2014,
Expert opinion on drug safety.
F. Goldwasser,
B. Borghese,
P. Boudou-Rouquette,
2016,
International Journal of Gynecologic Cancer.
A. Cottereau,
B. Blanchet,
A. Puszkiel,
2023,
Thyroid : official journal of the American Thyroid Association.
A. Thiery-Vuillemin,
E. Voog,
C. Helissey,
2023,
JAMA oncology.
O. Huillard,
R. Libé,
2023,
Cancer treatment and research communications.